David Giarracco

David Giarracco Email and Phone Number

CEO | Board Member | Angel Investor @ Noninvasix
David Giarracco's Location
Boulder, Colorado, United States, United States
David Giarracco's Contact Details

David Giarracco personal email

n/a

David Giarracco phone numbers

About David Giarracco

I am a medical device executive with over twenty-five years of leadership experience spanning quality, engineering, and operations including product line, business integrations and new product launches, six-sigma implementations for both operations and business process, and US and global marketing in surgical and monitoring environments.My leadership was crafted in big corporate America as well as within the start-up ecosystem. My experiences span business development (target identification, business case development, diligence), product development (concept through commercialization), into tactical commercial execution bringing innovative solutions to new sites. Market segments span the "admit to discharge" care continuum including the highest acuity in the OR/ICU through terminal chronic care and home care environments.Skills and Capabilities: Fund raisingBoard ManagementM&A including acquisition, commercial integration and divestiture of global businessSales and Marketing leadership across the healthcare continuumNew Business Opportunity Identification, Assessment and Business Case CreationStrategic PlanningGlobal Market DevelopmentProduct LaunchKey Opinion Leader ManagementClinical Claims Strategy and ManagementOperations ManagementSix Sigma & Lean ImplementationsOrganizational Development

David Giarracco's Current Company Details
Noninvasix

Noninvasix

View
CEO | Board Member | Angel Investor
David Giarracco Work Experience Details
  • Noninvasix
    Chief Executive Officer
    Noninvasix Nov 2021 - Present
    Galveston, Tx, Us
    Recruited by the board to fulfill the promise of Noninvasix and be the first to non-invasively monitor the severity of sepsis and septic shock, enabling clinicians to diagnose and monitor the response to treatment of tissue hypoxia in real-time. Our patented optoacoustic platform technology is the first solution to non-invasively and continuously measure central venous saturation. Incorporating Noninvasix into the ICU workflow allows clinicians to more quickly and accurately diagnose their critically ill patients and tailor treatments to improve outcomes. Future developments, enhancements, and evidence will expand the use and clinical impact of our technology into other indications and settings.
  • Venturewell
    Mentor
    Venturewell Aug 2019 - Present
    Hadley, Ma, Us
    ASPIRE is an intensive week-long workshop that prepares startups for the investments and partnerships necessary to launch their ventures. Mentors-in-residence works alongside startups to simulate due diligence conversations and integrate feedback into materials in real-time.
  • Nasaclip
    Advisor
    Nasaclip Feb 2020 - Present
    Baltimore, Maryland, Us
  • Caudate Consulting, Llc
    Founder
    Caudate Consulting, Llc Jul 2019 - Present
    Advised start-up companies in developing and executing their capital fundraising, operational and commercial strategies. Clients included TissueForm, Sachi Bioworks, and Nasaclip.
  • Seastar Medical
    Chief Operating Officer
    Seastar Medical Jun 2020 - Nov 2021
    Denver, Co, Us
    At SeaStar Medical we recognize that critical care clinicians fight every day to save patients from the cytokine storm. This deadly threat has taken too many organs and too many lives. The severity of this threat is our call to action. We leverage our scientific expertise and resources to break past limitations of current therapies and help our heroes in critical care stop the cytokine storm and save precious lives.
  • Tedco Builder Fund
    Executive
    Tedco Builder Fund Feb 2020 - May 2021
    The Builder Fund differentiates itself by identifying exceptional investment opportunities that are often overlooked by traditional funding organizations, by advancing the development of those opportunities. Companies selected for a Builder Fund qualify for investment and/or executive support to better position the company to receive follow-on, professional investment.
  • Spine Align, Llc
    Board Member
    Spine Align, Llc Dec 2020 - Jan 2021
    Baltimore, Maryland, Us
    The successful exit of the company that was acquired by a strategic purchaser and a great return to shareholders that believed in the vision.The World's first platform to enable real-time, 3D measurements of spinal alignment intraoperatively in less than 30 seconds and with up to 80% reduction in radiation exposure compared to current X-ray solutions.
  • Medtronic
    Vice President, Global Market Development Patient Monitoring & Recovery
    Medtronic Jan 2015 - Jun 2019
    Minneapolis, Mn, Us
    Established first global market development organization for Respiratory Compromise and Postoperative Neurocognitive Disorders.Drove multiple years of double-digit unit adoption and revenue growth, through multimedia awareness activities leveraging evidence and the development of novel services.Accelerated clinical evidence generation through cross-functional collaboration resulting in award winning clinical science and market expansion.Implemented a global, communication plan for clinical and economic evidence.Increased audience and awareness of evidence by strategic investments in PR and digital marketing. Demonstrated inspiration leadership resulting in employee survey result betters than benchmarks: engagement 98%, inclusion 94%, and innovation 91%; 5 consecutive quarters of growth.
  • Covidien
    Vice President, Pre Hospital Sales And Market Development
    Covidien Nov 2013 - Jan 2015
    Built EMS US commercial and market development organization accountable for revenue attainment.Achieved targets in FY14 and exceeded market growth of 14% in FY15, and 22% in FY16. Implemented market development function for $750M global Respiratory Compromise solutions portfolio.Established business case securing a 10 year $50M investment in Capnography to address barriers to adoption.Initiated $6.5M global post market clinical trial for demonstrating the clinical and economic impact of continuous, remote vital signs monitoring.Created Market Development Clinical Specialist organization to accelerate the technology adoption.Attained first enterprise level sale for the business by negotiating and closing $1.5M contract with a subsidiary of Capital Blue Cross.
  • Covidien
    Oridion Commercial Integration Lead
    Covidien Jun 2012 - Nov 2013
    Integrated the sales and marketing organizations of a multisite, multinational $346M Israeli acquisition with experience in restructuring the go-to-market organization.
  • Covidien
    Vice President, Marketing Patient Monitoring
    Covidien May 2010 - May 2012
    Hired and developed an organization of product management: implemented mid- year reviews, biannual talent reviews, and marketing journal club to drive culture change organization.
  • Covidien
    Acting Vp/Gm, Covidien Sleep & Oxygen Business
    Covidien Sep 2009 - Apr 2010
    Global business lead for the divestiture of Sleep and Liquid Oxygen Therapy franchises: completed three divestitures, led all aspects of contract negotiations covering US, European and Japan while demonstrating influence management over 450 Covidien employees globally.
  • Covidien
    Vice President Marketing, Homecare
    Covidien Jun 2008 - Sep 2009
    Vice President of Marketing for the Sleep and Oxygen business.
  • Covidien
    Vice President, Global Upstream Marketing
    Covidien Sep 2007 - Jun 2008
  • Covidien
    Director Global Market Development
    Covidien Jun 2007 - Sep 2007
    Lead the market development activities for a $1B respiratory & monitoring solutions medical device business focused on improving global outcomes in ventilation, monitoring and home healthcare. Defined, developed and recruited the initial market development department in the organization.
  • Covidien
    Global Product Marketing Director
    Covidien Oct 2006 - Jun 2007
    Lead the global marketing efforts for a $220M world-wide franchise in electrosurgery. Major repsonsibilities included recruiting a global product management organization, identifying new product opportunities, leadership through the new product development stage gate process, and marketing program identification and implementation.
  • Valleylab/Tycohealthcare
    Marketing Director
    Valleylab/Tycohealthcare Dec 2004 - Sep 2006
    Us
  • Valleylab/Tycohealthcare
    Manager, Operational Excellence
    Valleylab/Tycohealthcare Sep 2003 - Nov 2004
    Us
  • Cobe Cardiovascular
    Manufacturing Manager
    Cobe Cardiovascular Jan 1993 - Apr 2001
    Us

David Giarracco Skills

Business Integration Strategic Planning Product Launch Six Sigma Product Management Operations Management Medical Devices Organizational Development Product Development Key Opinion Leaders Strategy Capital Equipment Business Development Cardiology Management Healthcare Market Development Global Marketing Leadership Marketing Operating Room Commercialization Market Research Disposables Cross Functional Team Leadership Surgical Instruments Surgeons Iso 13485 Orthopedic Fda Biomedical Engineering Medical Imaging Surgery Design Control Urology Product Marketing Sales Operations Hospitals Competitive Analysis Sales Process Improvement Team Building Manufacturing Sales Management Business Process Improvement U.s. Food And Drug Administration Business Strategy Project Management Hospital Sales Culture Change Business Case Development Commercial Execution Divestitures Contract Negotiation

David Giarracco Education Details

  • The Johns Hopkins University School Of Medicine
    The Johns Hopkins University School Of Medicine
    Biomedical Engineering
  • The Johns Hopkins University
    The Johns Hopkins University
    Biomedical Engineering & Materials Science
  • Venture Capital Institute
    Venture Capital Institute

Frequently Asked Questions about David Giarracco

What company does David Giarracco work for?

David Giarracco works for Noninvasix

What is David Giarracco's role at the current company?

David Giarracco's current role is CEO | Board Member | Angel Investor.

What is David Giarracco's email address?

David Giarracco's email address is d.****@****ast.net

What is David Giarracco's direct phone number?

David Giarracco's direct phone number is +130388*****

What schools did David Giarracco attend?

David Giarracco attended The Johns Hopkins University School Of Medicine, The Johns Hopkins University, Venture Capital Institute.

What are some of David Giarracco's interests?

David Giarracco has interest in Kinder, Coaching Youth Soccer And Basketball.

What skills is David Giarracco known for?

David Giarracco has skills like Business Integration, Strategic Planning, Product Launch, Six Sigma, Product Management, Operations Management, Medical Devices, Organizational Development, Product Development, Key Opinion Leaders, Strategy, Capital Equipment.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.